Mirena, an Italian experience

Minerva Ginecologica

Volumn 63, Issue 4, 2011, Pages 343-349

  Bastianelli, C ^a   Farris, M ^a   Rapiti, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Contraception; Intrauterine devices; Levonorgestrel; Menorrhagia

Indexed keywords

LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; AMENORRHEA; BREAST TENDERNESS; CONDOM; CONTRACEPTION; DEVICE REMOVAL; DRUG EFFICACY; ECHOGRAPHY; FAMILY PLANNING; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DEVICE EXPULSION; INTRAUTERINE DEVICE MIGRATION; MENORRHAGIA; MENSTRUATION; OVARY CYST; PELVIC EXAMINATION; REVIEW; SAFETY; VAGINA SMEAR;

ADULT; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; ITALY; LEVONORGESTREL; MIDDLE AGED;

EID: 80054764792     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Pharris BB, Ericksson R, Bashow J, Hoff S, Place A, Zaffarono A. Progestasert®: A uterine therapeutic system for long term contraception: philosophy and clinical efficacy. Fertil Steril 1974;25:915.
2. Nilsson CG, Johansson EDB, Luukkainen T. A d-norgestrel-releasing IUD. Contraception 1976;13:503-14.
3. Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 1990;22:85-90. (Pubitemid 20193529)
4. Censis. I comportamenti sessuali degli italiani: falsi miti e nuove normalità - Considerazioni di sintesi. Roma, Luglio: Censis; 2000.
5. Luukkainen T, Nielsen N-C, Nygren K-G, Pydriili T. Nulliparouswomen, IUD and pelvic infection. Ann Clin Res 1979:11:121-4.
6. Diaz J, Pinto Neto AM, Bahamondcs L, Diaz M, Arce XE, Castro S. Performance of copper T 200 in parous adolescents: are copper IUDs suitable for these women' Contraception 1993:48:23-8. (Pubitemid 23214347)
7. Milsom I, Rybo G, Lindstedt G. The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. Contraception 1989;41:271-81. (Pubitemid 20085576)
8. Bastianelli C, Farris M, Testa G, Benagiano G. The Italian Mirena Study; five years experience with the Levonorgestrel releasing intrauterine system. Abstract Book Mirena Symposium "Benefits beyond Contraception"; 2003. p. 15,
9. Luukkainen T, Nielsen N-C, Nygren K-G, Pydriili T. Nulliparous women. IUD and pelvic infection. Ann Clin Res 1979:11:121-4. (Pubitemid 10242251)
10. Snowden R. The Progestasert and ectopic pregnancy. Br Med J 1977;2:1600-1.
11. Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol 1991;77:261-4.
12. Andersson K, Odlind V, Rybo G. Levonorgestrel releasing and copper releasing (Nova T) IUDs during five years of use. A randomized comparative study. Contraception 1994:49:56-72. (Pubitemid 24077388)
13. Bergkvist A, Rybo G. Treatment of menorrhagia with intrauterine release of progesterone. Br J Obstet Gynaecol 1983:90:255-8. (Pubitemid 13158616)
14. Milsom I, Andersson K, Andersch B, Rybo G. Comparison of flurbiprofen, trancxamic acid and a levonorgestrel-releasing intrauterine device in treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991:164:879-83.
15. Higham JM, O'Brien PM, Shaw RW Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-9. (Pubitemid 20263124)
16. Belsey EM, Farley TMM. The analysis of menstrual bleeding patterns: a review. Contraception 1988;38:129-567
17. Barbosa I, Bakos O, Olsson SE, Odlind V, Johansson ED. Ovarian function during use of a levonorgestrel-releasing IUD. Contraception 1990;42:51-66. (Pubitemid 20208812)
18. Nilsson CG, Lahteemaki PLA, Luukkainen T. Ovarian function in amenorrheic and menstruating users of a levonorgestrel releasing intrauterine device. Fertil Steril 1984;41:52-5. (Pubitemid 14181883)
19. French RS, Cowan FM, Mansour D, Higgins JPT, Robinson A, Procter T et al. Levonorgestrel-releasing (20 mg/day) intrauterine system (Mirena) compared with other method of reversible contraception. Br J Obstet Gynecol 2000;107:1218-25.
20. Luukkainen T, Pakarinen P. Progestin-releasing intra-uterine System. Reproductive Medicine 2001;19:355-63.
21. Standford JB, Mikolajczyk RT. Mechanism of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol 2002;187:1699-708. (Pubitemid 36026710)
22. Ortiz ME, Croxatto HB. Coppert-T and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception 2007;75:16-30S.
23. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20μg/d and Copper Tcu 380Ag intrauterine contraceptive devices: a multicentre study. Fertil Steril 1994;61:70-7. (Pubitemid 24030681)
24. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56-72. (Pubitemid 24077388)
25. Jensen JT. Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview. Obstetl Gynecol Surv 2005;69:604-12. (Pubitemid 41209328)
26. Luukkainen T, Allonen H, Haukkamaa M, Holma P, Pyörälä T, Terho J et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Contraception 1987;36:169-79. (Pubitemid 17159849)
27. Rose S, Chaudhari A, Peterson CM Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception. Adv Drug Deliv Rev 2009;10;61:808-12.
28. Lukkainen T. The levonorgestrel intrauterine system: therapeutic aspects. Steroids 2000;65:699-702.
29. Sivin I, Stern J, International Committee for Contraception Research. Health during prolonged use of levonorgestrel 20 pg/d and copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil Steril 1994;61:70-7. (Pubitemid 24030681)
30. Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel releasing intrauterine device and Nova T. Contraception 1992;46:575-84. (Pubitemid 23015722)
31. Belhadj H, Sivin I, Diaz S, Pavez M, Tejada AS, Brache V et al. Recovery of fertility after use of the levonorgestrel 20 μg/d or copper T 380Ag intrauterine device. Contraception 1986;34:261-7. (Pubitemid 17177018)
32. Guttinger A, Chritchley HOD. Endometrial effect of intrauterine levonorgestrel. Contraception. 2007; 75: 93-98S.
33. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. Effectiveness of the levonorgestrel releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynecol 2001;108:74-86. (Pubitemid 32102607)
34. Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynecol 1990;97:690-9.
35. Pakarinen P, Luukkainen T. Treatment of menorrhagia with a LNG-IUS. Contraception 2007;75:118-22S.
36. Varma R, Sinha D, Gupta JK. Non contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) - A systematic enquiry and overview. Eur J Obstet Gynecol Reprod Biol 2006;125:9-28.
37. Goñi AZ, Lacruz RL, Paricio JJ, Hernández Rivas FJ. The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia. Gynecol Endocrinol 2009;25:581-6.
38. Lete I, Obispo C, Izaguirre F, Orte T, Rivero B, Cornellana MJ et al.; Spanish Society of Gynaecology Obstetrics (SEGO). The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction. Eur J Contracept Reprod Health Care 2008;13:231-7.
39. Backman T, Huhtala S, Luoto R, Tuominen J, Rauramo I, Koskenvuo M. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol 2002;99:608-13. (Pubitemid 34246299)
40. Pakarinen P, Toivonene J, Luukkainen T. Therapeutic use of the LNG and counselling. Sem Reprod Med 2001;19:365-72.
41. Beatty MN, Blumenthal PD. The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability. Ther Clin Risk Manag 2009;5:561-74.
42. Pakarinen PI, Suvisaari J, Luukkainen T, Lähteenmäki P. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding and persisting ovarian follicles. Fertil Steril 1997;68:59-64. (Pubitemid 27283717)
43. Chi IC, Farr G. The non-contraceptive effects of the levonorgestrel releasing intrauterine device. Adv Contraception 1994;10:271-85.
44. Robinson GE, Bounds W, Kubba AA, Adams J, Guillebaud J. Functional ovarian cysts associated with the levonorgestrel releasing intrauterine device. Br J Fam Plann 1989;14:131-2. (Pubitemid 19037358)